Icad Inc Stock Performance
| ICAD Stock | USD 1.97 0.08 4.23% |
On a scale of 0 to 100, Icad holds a performance score of 7. The company retains a Market Volatility (i.e., Beta) of 1.51, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Icad will likely underperform. Please check Icad's jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Icad's current trending patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in icad inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Icad exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:5 | Last Split Date 2012-08-16 |
1 | icad Inc Q2 2024 Earnings Call Highlights Strong Revenue Growth and Strategic Shifts | 10/09/2024 |
2 | iCAD adds US15m to market cap in the past 7 days, though investors from three years ago are still down 82 | 10/17/2024 |
3 | Acquisition by Hricak Hedvig of 40000 shares of Icad at 1.36 subject to Rule 16b-3 | 11/05/2024 |
4 | iCAD Non-GAAP EPS of -0.07 beats by 0.01, revenue of 4.2M misses by 0.42M | 11/13/2024 |
5 | icad Inc Q3 2024 Earnings Call Highlights Revenue Growth Amidst Strategic Shifts | 11/14/2024 |
6 | iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024 | 11/26/2024 |
7 | CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA ... | 12/04/2024 |
| Begin Period Cash Flow | 21.3 M |
Icad |
Icad Relative Risk vs. Return Landscape
If you would invest 152.00 in icad inc on September 12, 2024 and sell it today you would earn a total of 45.00 from holding icad inc or generate 29.61% return on investment over 90 days. icad inc is currently generating 0.5824% in daily expected returns and assumes 5.9663% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of stocks are less volatile than Icad, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Icad Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Icad's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as icad inc, and traders can use it to determine the average amount a Icad's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0976
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ICAD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.97 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.58 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Icad is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Icad by adding it to a well-diversified portfolio.
Icad Fundamentals Growth
Icad Stock prices reflect investors' perceptions of the future prospects and financial health of Icad, and Icad fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Icad Stock performance.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0767 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.39) % | ||||
| Current Valuation | 31.17 M | ||||
| Shares Outstanding | 26.35 M | ||||
| Price To Earning | (8.32) X | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 2.65 X | ||||
| Revenue | 17.32 M | ||||
| Gross Profit | 20.11 M | ||||
| EBITDA | (6.57 M) | ||||
| Net Income | (4.85 M) | ||||
| Cash And Equivalents | 27.18 M | ||||
| Cash Per Share | 1.07 X | ||||
| Total Debt | 461 K | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 3.19 X | ||||
| Book Value Per Share | 1.27 X | ||||
| Cash Flow From Operations | (4.96 M) | ||||
| Earnings Per Share | (0.20) X | ||||
| Market Capitalization | 49.81 M | ||||
| Total Asset | 41.42 M | ||||
| Retained Earnings | (271.68 M) | ||||
| Working Capital | 22.93 M | ||||
| Current Asset | 27.77 M | ||||
| Current Liabilities | 14.28 M | ||||
About Icad Performance
By analyzing Icad's fundamental ratios, stakeholders can gain valuable insights into Icad's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Icad has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Icad has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 120.31 | 202.68 | |
| Return On Tangible Assets | (0.15) | (0.15) | |
| Return On Capital Employed | (0.22) | (0.23) | |
| Return On Assets | (0.12) | (0.12) | |
| Return On Equity | (0.15) | (0.15) |
Things to note about icad inc performance evaluation
Checking the ongoing alerts about Icad for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for icad inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| icad inc is way too risky over 90 days horizon | |
| icad inc may become a speculative penny stock | |
| icad inc appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 17.32 M. Net Loss for the year was (4.85 M) with profit before overhead, payroll, taxes, and interest of 20.11 M. | |
| icad inc currently holds about 27.18 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07. | |
| icad inc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024 |
- Analyzing Icad's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Icad's stock is overvalued or undervalued compared to its peers.
- Examining Icad's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Icad's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Icad's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Icad's stock. These opinions can provide insight into Icad's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Icad Stock analysis
When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |